GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Median Technologies (XPAR:ALMDT) » Definitions » Gross Margin %

Median Technologies (XPAR:ALMDT) Gross Margin % : 104.87% (As of Dec. 2023)


View and export this data going back to 2011. Start your Free Trial

What is Median Technologies Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Median Technologies's Gross Profit for the six months ended in Dec. 2023 was €11.43 Mil. Median Technologies's Revenue for the six months ended in Dec. 2023 was €10.90 Mil. Therefore, Median Technologies's Gross Margin % for the quarter that ended in Dec. 2023 was 104.87%.


The historical rank and industry rank for Median Technologies's Gross Margin % or its related term are showing as below:

XPAR:ALMDT' s Gross Margin % Range Over the Past 10 Years
Min: 96.63   Med: 98.57   Max: 104.5
Current: 104.5


During the past 13 years, the highest Gross Margin % of Median Technologies was 104.50%. The lowest was 96.63%. And the median was 98.57%.

XPAR:ALMDT's Gross Margin % is ranked better than
98.25% of 801 companies
in the Medical Devices & Instruments industry
Industry Median: 52.9 vs XPAR:ALMDT: 104.50

Median Technologies had a gross margin of 104.87% for the quarter that ended in Dec. 2023 => Durable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Median Technologies was 1.30% per year.


Median Technologies Gross Margin % Historical Data

The historical data trend for Median Technologies's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Median Technologies Gross Margin % Chart

Median Technologies Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 98.85 99.00 99.43 103.17 104.50

Median Technologies Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 99.39 99.41 107.54 104.14 104.87

Competitive Comparison of Median Technologies's Gross Margin %

For the Medical Devices subindustry, Median Technologies's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Median Technologies's Gross Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Median Technologies's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Median Technologies's Gross Margin % falls into.



Median Technologies Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Median Technologies's Gross Margin for the fiscal year that ended in Dec. 2023 is calculated as

Gross Margin % (A: Dec. 2023 )=Gross Profit (A: Dec. 2023 ) / Revenue (A: Dec. 2023 )
=23.2 / 22.226
=(Revenue - Cost of Goods Sold) / Revenue
=(22.226 - -1) / 22.226
=104.50 %

Median Technologies's Gross Margin for the quarter that ended in Dec. 2023 is calculated as


Gross Margin % (Q: Dec. 2023 )=Gross Profit (Q: Dec. 2023 ) / Revenue (Q: Dec. 2023 )
=11.4 / 10.899
=(Revenue - Cost of Goods Sold) / Revenue
=(10.899 - -0.531) / 10.899
=104.87 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Median Technologies  (XPAR:ALMDT) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Median Technologies had a gross margin of 104.87% for the quarter that ended in Dec. 2023 => Durable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Median Technologies Gross Margin % Related Terms

Thank you for viewing the detailed overview of Median Technologies's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Median Technologies (XPAR:ALMDT) Business Description

Traded in Other Exchanges
Address
1800 Route Des Cretes, Les Deux Arcs B, Valbonne, FRA, 06560
Median Technologies is engaged in providing medical imaging products and services for diagnosing and monitoring cancer patients in both routine clinical practice and clinical drug development. The firm intends to target the oncology clinical trials market and the cancer patient care market. It developed software-based tools that are integrated into a clinical application portfolio called Lesion Management Solutions. The company has two platforms, iSee for imaging services in clinical trials and iBiopsy for non-invasive diagnostic tests based on imaging for the treatment of patients suffering from cancer and other chronic diseases. Its geographical segments are France, the USA/Canada, the United Kingdom, China, and Other countries.

Median Technologies (XPAR:ALMDT) Headlines

No Headlines